Regenerative Medicine

A highly anticipated drug trial is in its final stages as its 350 participants receive their single dose to treat chronic low back pain. If successful, it could be a breakthrough therapeutic for people with the debilitating age-related condition.

An experiment conducted by a team of researchers from Texas A&M University has revealed a healing sequence in mammalian physiology that rebuilds lost skeletal structure, albeit with less than perfect results.